天圣制药集团股份有限公司 关于公司及子公司参加国家组织集采药品协议期满品种接续采购拟中选的公告

Group 1 - The company and its subsidiary, Hubei Tiensheng Pharmaceutical Co., Ltd., participated in the national organized procurement for drugs whose agreements have expired, and some products are proposed to be selected for this procurement [1] - If the procurement contracts are signed and implemented, it will help expand the sales range of the relevant products, increase market share, and enhance brand influence [1] Group 2 - The announcement was made on February 11, 2026, by the board of directors of Tiensheng Pharmaceutical Group Co., Ltd. [2]